This study is in progress, not accepting new patients
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA UCSD UCSF
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Arcus Biosciences, Inc.
- Links
- PRISM-1 - Public website
- ID
- NCT06608927
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 610 study participants
- Last Updated